TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Cross-sectional Population Representative Internet Survey to Estimate Prevalence of Lower Urinary Tract Symptoms (LUTS) in China, Taiwan and South Korea
Brief Summary: The purpose of the study is to determine prevalence of lower urinary tract symptoms in population aged 40 years or over, in China, Taiwan and South Korea using latest ICS definition.


Options:
A: Arm Label: UroLift System; Type: ACTIVE_COMPARATOR; Interventions: Device: UroLift System | Arm Label: Cystoscopy; Type: SHAM_COMPARATOR; Interventions: Other: Cystoscopy | Arm Label: Crossover; Type: ACTIVE_COMPARATOR; Interventions: Device: Crossover | Intervention Type: DEVICE; Name: UroLift System; Assigned to Arm(s): UroLift System | Intervention Type: OTHER; Name: Cystoscopy; Assigned to Arm(s): Cystoscopy | Intervention Type: DEVICE; Name: Crossover; Assigned to Arm(s): Crossover
B: Arm Label: UroLift System; Type: ACTIVE_COMPARATOR; Interventions: Device: UroLift System | Arm Label: Transurethral Resection of the Prostate; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Transurethral Resection of the Prostate | Intervention Type: DEVICE; Name: UroLift System; Assigned to Arm(s): UroLift System | Intervention Type: PROCEDURE; Name: Transurethral Resection of the Prostate; Assigned to Arm(s): Transurethral Resection of the Prostate
C: Arm Label: Participants Aged 40 Years or Over; Type: N/A; Interventions: N/A
D: Arm Label: Treatment; Type: EXPERIMENTAL; Interventions: Device: Rezum System | Arm Label: Control; Type: OTHER; Interventions: Procedure: Rigid Cystoscopy | Intervention Type: DEVICE; Name: Rezum System; Assigned to Arm(s): Treatment | Intervention Type: PROCEDURE; Name: Rigid Cystoscopy; Assigned to Arm(s): Control

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Intravenous Versus Combined Oral and Intravenous Antimicrobial Prophylaxis for the Prevention of Surgical Site Infection in Elective Colorectal Surgery: A Double-blinded Multicenter Prospective Randomized Controlled Trial
Brief Summary: To assess the effects of a combined antimicrobial prophylaxis using oral ornidazole (the day before surgery) and intravenous cephalosporin (before surgical incision) with that of intravenous cephalosporin alone (standard of care) in combination with oral placebo on the incidence of SSI within 30 days after elective colorectal surgery.


Options:
A: Arm Label: Arm I (mechanical bowel prep, oral antibiotics); Type: ACTIVE_COMPARATOR; Interventions: Drug: Polyethylene Glycol, Drug: Neomycin, Drug: Metronidazole Hydrochloride, Procedure: Therapeutic Conventional Surgery | Arm Label: Arm II (oral antibiotics); Type: EXPERIMENTAL; Interventions: Drug: Neomycin, Drug: Metronidazole Hydrochloride, Procedure: Therapeutic Conventional Surgery | Intervention Type: DRUG; Name: Polyethylene Glycol; Assigned to Arm(s): Arm I (mechanical bowel prep, oral antibiotics) | Intervention Type: DRUG; Name: Neomycin; Assigned to Arm(s): Arm I (mechanical bowel prep, oral antibiotics), Arm II (oral antibiotics) | Intervention Type: DRUG; Name: Metronidazole Hydrochloride; Assigned to Arm(s): Arm I (mechanical bowel prep, oral antibiotics), Arm II (oral antibiotics) | Intervention Type: PROCEDURE; Name: Therapeutic Conventional Surgery; Assigned to Arm(s): Arm I (mechanical bowel prep, oral antibiotics), Arm II (oral antibiotics)
B: Arm Label: ornidazole; Type: EXPERIMENTAL; Interventions: Drug: ornidazole | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: ornidazole; Assigned to Arm(s): ornidazole | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): placebo
C: Arm Label: Oral with Intravenous; Type: EXPERIMENTAL; Interventions: Drug: Oral antibiotic, Drug: Intravenous antibiotic, Drug: Mechanical Bowel Preparation | Arm Label: Intravenous; Type: ACTIVE_COMPARATOR; Interventions: Drug: Intravenous antibiotic, Drug: Mechanical Bowel Preparation | Intervention Type: DRUG; Name: Oral antibiotic; Assigned to Arm(s): Oral with Intravenous | Intervention Type: DRUG; Name: Intravenous antibiotic; Assigned to Arm(s): Intravenous, Oral with Intravenous | Intervention Type: DRUG; Name: Mechanical Bowel Preparation; Assigned to Arm(s): Intravenous, Oral with Intravenous
D: Arm Label: Bowel Preparation plus antibiotics; Type: ACTIVE_COMPARATOR; Interventions: Other: Bowel Preparation plus antibiotics | Arm Label: Bowel Preparation; Type: OTHER; Interventions: Other: Bowel Preparation | Intervention Type: OTHER; Name: Bowel Preparation plus antibiotics; Assigned to Arm(s): Bowel Preparation plus antibiotics | Intervention Type: OTHER; Name: Bowel Preparation; Assigned to Arm(s): Bowel Preparation

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Myocardial Ischemia and Transfusion: A Pilot, Multi-centre, Open-label Randomized Controlled Trial of Two Commonly Used Transfusion Strategies in Patients With Myocardial Infarction.
Brief Summary: MINT: A pilot, multi-centre, open-label randomized controlled trial of two commonly used transfusion strategies in patients with myocardial infarction.


Options:
A: Arm Label: Restrictive transfusion strategy; Type: ACTIVE_COMPARATOR; Interventions: Other: Restrictive Transfusion Strategy | Arm Label: Liberal transfusion strategy; Type: ACTIVE_COMPARATOR; Interventions: Other: Liberal transfusion strategy | Intervention Type: OTHER; Name: Restrictive Transfusion Strategy; Assigned to Arm(s): Restrictive transfusion strategy | Intervention Type: OTHER; Name: Liberal transfusion strategy; Assigned to Arm(s): Liberal transfusion strategy
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Transfusion with Red Blood Cells, Biological: 1 unit of donated red blood cells | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Biological: 1 unit of donated red blood cells | Intervention Type: PROCEDURE; Name: Transfusion with Red Blood Cells; Assigned to Arm(s): 1 | Intervention Type: BIOLOGICAL; Name: 1 unit of donated red blood cells; Assigned to Arm(s): 1 | Intervention Type: BIOLOGICAL; Name: 1 unit of donated red blood cells; Assigned to Arm(s): 2
C: Arm Label: Restrictive Transfusion Strategy; Type: EXPERIMENTAL; Interventions: Procedure: Transfusion | Arm Label: Liberal Transfusion Strategy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Transfusion | Intervention Type: PROCEDURE; Name: Transfusion; Assigned to Arm(s): Liberal Transfusion Strategy, Restrictive Transfusion Strategy
D: Arm Label: Liberal Transfusion Strategy; Type: ACTIVE_COMPARATOR; Interventions: Other: Red blood cell transfusion | Arm Label: Restrictive Transfusion Strategy; Type: ACTIVE_COMPARATOR; Interventions: Other: Red blood cell transfusion | Intervention Type: OTHER; Name: Red blood cell transfusion; Assigned to Arm(s): Liberal Transfusion Strategy | Intervention Type: OTHER; Name: Red blood cell transfusion; Assigned to Arm(s): Restrictive Transfusion Strategy

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Myocardial Ischemia and Transfusion: A Pilot, Multi-centre, Open-label Randomized Controlled Trial of Two Commonly Used Transfusion Strategies in Patients With Myocardial Infarction.
Brief Summary: MINT: A pilot, multi-centre, open-label randomized controlled trial of two commonly used transfusion strategies in patients with myocardial infarction.


Options:
A: Arm Label: Allowed drop in hemoglobin to 4.5-5.5 mmol/L; Type: ACTIVE_COMPARATOR; Interventions: Other: Allowed drop in hemoglobin to 4.5-5.5 mmol/L | Arm Label: Allowed drop in hemoglobin to 5.6-6.5 mmol/L; Type: EXPERIMENTAL; Interventions: Other: Allowed drop in hemoglobin to level between 5.6-6.5 mmol/L | Intervention Type: OTHER; Name: Allowed drop in hemoglobin to 4.5-5.5 mmol/L; Assigned to Arm(s): Allowed drop in hemoglobin to 4.5-5.5 mmol/L | Intervention Type: OTHER; Name: Allowed drop in hemoglobin to level between 5.6-6.5 mmol/L; Assigned to Arm(s): Allowed drop in hemoglobin to 5.6-6.5 mmol/L
B: Arm Label: Restrictive Transfusion Strategy; Type: EXPERIMENTAL; Interventions: Procedure: Transfusion | Arm Label: Liberal Transfusion Strategy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Transfusion | Intervention Type: PROCEDURE; Name: Transfusion; Assigned to Arm(s): Liberal Transfusion Strategy, Restrictive Transfusion Strategy
C: Arm Label: Liberal; Type: ACTIVE_COMPARATOR; Interventions: Other: Liberal transfusion threshold | Arm Label: Restrictive; Type: ACTIVE_COMPARATOR; Interventions: Other: Restrictive transfusion threshold | Intervention Type: OTHER; Name: Restrictive transfusion threshold; Assigned to Arm(s): Restrictive | Intervention Type: OTHER; Name: Liberal transfusion threshold; Assigned to Arm(s): Liberal
D: Arm Label: Liberal; Type: EXPERIMENTAL; Interventions: Drug: red blood cell transfusion trigger | Arm Label: Restrictive; Type: ACTIVE_COMPARATOR; Interventions: Drug: red blood cell transfusion trigger | Intervention Type: DRUG; Name: red blood cell transfusion trigger; Assigned to Arm(s): Liberal, Restrictive

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Myocardial Ischemia and Transfusion: A Pilot, Multi-centre, Open-label Randomized Controlled Trial of Two Commonly Used Transfusion Strategies in Patients With Myocardial Infarction.
Brief Summary: MINT: A pilot, multi-centre, open-label randomized controlled trial of two commonly used transfusion strategies in patients with myocardial infarction.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tranexamic acid (Exacyl) | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Tranexamic acid (Exacyl); Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2
B: Arm Label: Blood transfusion triggers of 24% hematocrit value; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Blood transfusion at hematocrit value less than 24% | Arm Label: Blood transfusion triggers of 28% hematocrit value; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Blood transfusion at hematocrit value less than 28% | Intervention Type: PROCEDURE; Name: Blood transfusion at hematocrit value less than 24%; Assigned to Arm(s): Blood transfusion triggers of 24% hematocrit value | Intervention Type: PROCEDURE; Name: Blood transfusion at hematocrit value less than 28%; Assigned to Arm(s): Blood transfusion triggers of 28% hematocrit value
C: Arm Label: Blood transfusion; Type: EXPERIMENTAL; Interventions: Biological: Blood transfusion | Intervention Type: BIOLOGICAL; Name: Blood transfusion; Assigned to Arm(s): Blood transfusion
D: Arm Label: Restrictive Transfusion Strategy; Type: EXPERIMENTAL; Interventions: Procedure: Transfusion | Arm Label: Liberal Transfusion Strategy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Transfusion | Intervention Type: PROCEDURE; Name: Transfusion; Assigned to Arm(s): Liberal Transfusion Strategy, Restrictive Transfusion Strategy

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Physical Exercise With Flow Restriction on the Diameter and the Flow of the Blood Vessels of the Forearm in Chronic Kidney Disease: a Randomized Clinical Trial
Brief Summary: The aim of this study is to analyze the effectiveness of physical exercise with blood flow restriction on the diameter and the flow of vessels, muscle strength and circumference of the forearm in patients with CKD prior to making FAV.


Options:
A: Arm Label: Control Arm; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Exercise Arm; Type: EXPERIMENTAL; Interventions: Behavioral: Hand Exercise | Intervention Type: BEHAVIORAL; Name: Hand Exercise; Assigned to Arm(s): Exercise Arm
B: Arm Label: Experimental group; Type: EXPERIMENTAL; Interventions: Other: experimental group | Arm Label: Group control; Type: SHAM_COMPARATOR; Interventions: Other: experimental group | Intervention Type: OTHER; Name: experimental group; Assigned to Arm(s): Experimental group, Group control
C: Arm Label: Repetitive handgrip exercise; Type: EXPERIMENTAL; Interventions: Other: Repetitive arm exercise | Arm Label: No arm exercise; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Repetitive arm exercise; Assigned to Arm(s): Repetitive handgrip exercise
D: Arm Label: The handgrip exercise; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: The handgrip exercise | Arm Label: The dumbbell exercise; Type: EXPERIMENTAL; Interventions: Behavioral: The dumbbell exercise | Intervention Type: BEHAVIORAL; Name: The handgrip exercise; Assigned to Arm(s): The handgrip exercise | Intervention Type: BEHAVIORAL; Name: The dumbbell exercise; Assigned to Arm(s): The dumbbell exercise

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Clinical Impact of Hypothermic Machine Perfusion in Renal Transplant Recipients
Brief Summary: This is a multi-centers prospective, randomized, controlled trial. This trial will investigate the clinical outcome of kidney transplant recipients whose kidneys are under two different forms of organ preservation--hypothermic machine perfusion vs. static cold storage. Factors during the machine perfusion, such as the pressure, flow rate, and resistance index will also be investigated.


Options:
A: Arm Label: cold storage; Type: ACTIVE_COMPARATOR; Interventions: Device: cold storage | Arm Label: Kidney Transporter machines; Type: ACTIVE_COMPARATOR; Interventions: Device: Kidney Transporter machines | Intervention Type: DEVICE; Name: Kidney Transporter machines; Assigned to Arm(s): Kidney Transporter machines | Intervention Type: DEVICE; Name: cold storage; Assigned to Arm(s): cold storage
B: Arm Label: Static incubation; Type: OTHER; Interventions: Procedure: Static incubation | Arm Label: Pulsatile perfusion; Type: EXPERIMENTAL; Interventions: Procedure: Pulsatile perfusion | Intervention Type: PROCEDURE; Name: Static incubation; Assigned to Arm(s): Static incubation | Intervention Type: PROCEDURE; Name: Pulsatile perfusion; Assigned to Arm(s): Pulsatile perfusion
C: Arm Label: Normothermic machine perfusion (NMP); Type: EXPERIMENTAL; Interventions: Device: End-ischemic normothermic oxygenated machine perfusion | Arm Label: Statical cold storage (SCS); Type: ACTIVE_COMPARATOR; Interventions: Procedure: Static cold storage | Intervention Type: DEVICE; Name: End-ischemic normothermic oxygenated machine perfusion; Assigned to Arm(s): Normothermic machine perfusion (NMP) | Intervention Type: PROCEDURE; Name: Static cold storage; Assigned to Arm(s): Statical cold storage (SCS)
D: Arm Label: Hypothermic Machine Perfusion; Type: EXPERIMENTAL; Interventions: Device: Hypothermic Machine Perfusion | Arm Label: Normothermic Machine Perfusion; Type: EXPERIMENTAL; Interventions: Device: Normothermic Machine Perfusion | Intervention Type: DEVICE; Name: Hypothermic Machine Perfusion; Assigned to Arm(s): Hypothermic Machine Perfusion | Intervention Type: DEVICE; Name: Normothermic Machine Perfusion; Assigned to Arm(s): Normothermic Machine Perfusion

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab (TEV-48125) Versus Placebo for the Preventive Treatment of Chronic Migraine
Brief Summary: The study is being conducted to evaluate two doses of TEV-48125 in adult patients with chronic migraine


Options:
A: Arm Label: botulinum toxin Type A; Type: EXPERIMENTAL; Interventions: Biological: Botulinum Toxin Type A | Arm Label: Placebo (saline); Type: PLACEBO_COMPARATOR; Interventions: Other: placebo (saline) | Intervention Type: BIOLOGICAL; Name: Botulinum Toxin Type A; Assigned to Arm(s): botulinum toxin Type A | Intervention Type: OTHER; Name: placebo (saline); Assigned to Arm(s): Placebo (saline)
B: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Fremanezumab 675 mg/placebo/placebo; Type: EXPERIMENTAL; Interventions: Drug: Fremanezumab, Drug: Placebo | Arm Label: Fremanezumab 675/225/225 mg; Type: EXPERIMENTAL; Interventions: Drug: Fremanezumab | Intervention Type: DRUG; Name: Fremanezumab; Assigned to Arm(s): Fremanezumab 675 mg/placebo/placebo, Fremanezumab 675/225/225 mg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Fremanezumab 675 mg/placebo/placebo, Placebo
C: Arm Label: botulinum toxin Type A; Type: EXPERIMENTAL; Interventions: Biological: Botulinum Toxin Type A | Arm Label: Placebo (saline); Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo (saline) | Intervention Type: BIOLOGICAL; Name: Botulinum Toxin Type A; Assigned to Arm(s): botulinum toxin Type A | Intervention Type: OTHER; Name: Placebo (saline); Assigned to Arm(s): Placebo (saline)
D: Intervention Type: DRUG; Name: Botulinum toxin A injection or normal saline; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Promoting Weight Loss Through Diet and Exercise in Overweight Women With Breast Cancer: A Four-arm Randomized Trial
Brief Summary: The investigators aim to evaluate the effect of a 6-month intervention (counseling) focused on weight loss in a group of overweight or obese women previously treated for early breast cancer. Intervention is designed to improve adherence to a healthy diet or/and to increase physical activity and decrease sedentary time, taking advantage of a pedometer-like device.


Options:
A: Arm Label: DI Dietary Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: DI | Arm Label: PAI Physical Activity Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: PAI | Arm Label: PADI Physical Activity+Diet Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: PADI | Arm Label: LII Less Intensive Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: LII | Intervention Type: BEHAVIORAL; Name: DI; Assigned to Arm(s): DI Dietary Intervention | Intervention Type: BEHAVIORAL; Name: PAI; Assigned to Arm(s): PAI Physical Activity Intervention | Intervention Type: BEHAVIORAL; Name: PADI; Assigned to Arm(s): PADI Physical Activity+Diet Intervention | Intervention Type: BEHAVIORAL; Name: LII; Assigned to Arm(s): LII Less Intensive Intervention
B: Arm Label: Less Intensive Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Less Intensive | Arm Label: Intensive Group; Type: EXPERIMENTAL; Interventions: Behavioral: Intensive Group | Intervention Type: BEHAVIORAL; Name: Less Intensive; Assigned to Arm(s): Less Intensive Group | Intervention Type: BEHAVIORAL; Name: Intensive Group; Assigned to Arm(s): Intensive Group
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive behavioral therapy CBT) for weight loss | Intervention Type: BEHAVIORAL; Name: Cognitive behavioral therapy CBT) for weight loss; Assigned to Arm(s): 1
D: Arm Label: Wait-list control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Lifestyle counseling; Type: EXPERIMENTAL; Interventions: Behavioral: behavioral dietary and exercise intervention | Intervention Type: BEHAVIORAL; Name: behavioral dietary and exercise intervention; Assigned to Arm(s): Lifestyle counseling

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Use of Pedometers to Measure and Increase Walking Among Patients With ESRD
Brief Summary: Randomized controlled trial using pedometers to increase physical activity among patients on dialysis.


Options:
A: Arm Label: Exercise; Type: EXPERIMENTAL; Interventions: Other: Exercise | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Exercise; Assigned to Arm(s): Exercise
B: Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: activity group; Type: EXPERIMENTAL; Interventions: Device: Exercise training in addition to nutritional support | Intervention Type: DEVICE; Name: Exercise training in addition to nutritional support; Assigned to Arm(s): activity group
C: Arm Label: pedometer; Type: EXPERIMENTAL; Interventions: Behavioral: pedometer | Arm Label: usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: pedometer; Assigned to Arm(s): pedometer
D: Arm Label: Standard Dialysis; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Typical Dialysis, Procedure: Exercise | Arm Label: Cold Dialysis; Type: EXPERIMENTAL; Interventions: Procedure: Cold Dialysis, Procedure: Exercise | Intervention Type: PROCEDURE; Name: Cold Dialysis; Assigned to Arm(s): Cold Dialysis | Intervention Type: PROCEDURE; Name: Typical Dialysis; Assigned to Arm(s): Standard Dialysis | Intervention Type: PROCEDURE; Name: Exercise; Assigned to Arm(s): Cold Dialysis, Standard Dialysis

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Stay Healthy In Nature Everyday: a Randomized Controlled Trial of the Effect of Family Nature Outings on Stress and Physical Inactivity in a Low Income Population
Brief Summary: The SHINE study is a randomized controlled study of the effect of a park-based family support group on multiple outcomes (including stress and physical activity) in a low income population.


Options:
A: Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Face-to-face family mentoring and education sessions, Behavioral: Telephone follow-up | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Face-to-face family mentoring and education sessions; Assigned to Arm(s): Intervention Group | Intervention Type: BEHAVIORAL; Name: Telephone follow-up; Assigned to Arm(s): Intervention Group
B: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Students for Nutrition and eXercise; Type: EXPERIMENTAL; Interventions: Behavioral: Students for Nutrition and eXercise | Intervention Type: BEHAVIORAL; Name: Students for Nutrition and eXercise; Assigned to Arm(s): Students for Nutrition and eXercise
C: Arm Label: Park prescription; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Park prescription, Device: Pedometry | Arm Label: Park prescription and family outings; Type: EXPERIMENTAL; Interventions: Behavioral: Family outings, Behavioral: Park prescription, Device: Pedometry, Behavioral: Case Management | Intervention Type: BEHAVIORAL; Name: Family outings; Assigned to Arm(s): Park prescription and family outings | Intervention Type: BEHAVIORAL; Name: Park prescription; Assigned to Arm(s): Park prescription, Park prescription and family outings | Intervention Type: DEVICE; Name: Pedometry; Assigned to Arm(s): Park prescription, Park prescription and family outings | Intervention Type: BEHAVIORAL; Name: Case Management; Assigned to Arm(s): Park prescription and family outings
D: Arm Label: Learning to Breathe; Type: EXPERIMENTAL; Interventions: Behavioral: Learning to Breathe | Arm Label: Health Education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Health Education | Intervention Type: BEHAVIORAL; Name: Learning to Breathe; Assigned to Arm(s): Learning to Breathe | Intervention Type: BEHAVIORAL; Name: Health Education; Assigned to Arm(s): Health Education

Answer: C